- Rank in Search Criteria: 4191
World Rank (Jan-05-2024): 13,959
Market Cap (Jan-05-2024): 0.40 Billion USD
World Rank (Jul-30-2023): 14141
Market Cap (Jul-30-2023): 0.40 Billion USD
World Rank (Jan-2022): 13,249
Market Cap (Jan-2022): 0.52 Billion USDHeadquarters Country: USA Annual Revenue in USD: 133 Million USD
Annual Net Income in USD: 69 Million USD
Annual Results for Period ending: Dec-2021 ending yearEmployee Count: 39
Employee Count as of Date: As on 2021
Company Profile: SIGA Technologies is a Public and Commercial Stage Pharmaceutical company focused on providing solutions for unmet needs in the health security market that comprises medical countermeasures against chemical, biological, radiological and nuclear (CBRN) threats as well as emerging infectious diseases. The company annual revenue is 127.2 million USD and 41 employees as on 2020. The headquarters is in USA.
- Rank in Search Criteria: 4192
World Rank (Jan-05-2024): 13,963
Market Cap (Jan-05-2024): 0.40 Billion USD
World Rank (Jul-30-2023): 14097
Market Cap (Jul-30-2023): 0.40 Billion USD
World Rank (Jan-2022): 13,159
Market Cap (Jan-2022): 0.53 Billion USDHeadquarters Country: USA Annual Revenue in USD: 127 Million USD
Annual Net Income in USD: 29 Million USD
Annual Results for Period ending: Dec-2021 ending yearEmployee Count: 619
Employee Count as of Date: As on 2021
- Rank in Search Criteria: 4193
World Rank (Jan-05-2024): 13,965
Market Cap (Jan-05-2024): 0.40 Billion USD
World Rank (Jul-30-2023): 12768
Market Cap (Jul-30-2023): 0.50 Billion USD
World Rank (Jan-2022): 7,393
Market Cap (Jan-2022): 1.52 Billion USDHeadquarters Country: USA Annual Revenue in USD: 344 Million USD
Annual Net Income in USD: 214 Million USD
Annual Results for Period ending: Dec-2021 ending yearCompany Profile: iTeos Therapeutics is a Clinical Stage Biopharmaceutical Company pioneering the discovery and development of a new generation of highly differentiated immuno oncology therapeutics for patients. It innovative pipeline includes two clinical stage programs targeting novel, validated immuno oncology pathways designed to build on prior learnings in the field to have differentiated pharmacological and clinical profiles. The headquarters is in USA.
- Rank in Search Criteria: 4194
World Rank (Jan-05-2024): 13,968
World Rank (Jul-30-2023): 13968
World Rank (Jan-2022): 13,968
Headquarters Country: USA Annual Revenue in USD: 54 Million USD
Annual Net Income in USD: 4 Million USD
Annual Results for Period ending: Dec-2020 ending year
- Rank in Search Criteria: 4195
World Rank (Jan-05-2024): 13,968
Market Cap (Jan-05-2024): 0.40 Billion USD
World Rank (Jul-30-2023): 16664
Market Cap (Jul-30-2023): 0.26 Billion USD
World Rank (Jan-2022): 19,848
Market Cap (Jan-2022): 0.17 Billion USD
- Rank in Search Criteria: 4196
World Rank (Jan-05-2024): 13,978
Market Cap (Jan-05-2024): 0.40 Billion USD
World Rank (Jul-30-2023): 14619
Market Cap (Jul-30-2023): 0.37 Billion USD
World Rank (Jan-2022): 7,980
Market Cap (Jan-2022): 1.33 Billion USDHeadquarters Country: USA Annual Revenue in USD: 2,054 Million USD
Annual Net Income in USD: -448 Million USD
Annual Results for Period ending: Dec-2021 ending yearEmployee Count: 16,300
Employee Count as of Date: As on 2021
Company Profile: Software and IT company with headquarters is in USA.
- Rank in Search Criteria: 4197
World Rank (Jan-05-2024): 13,986
Market Cap (Jan-05-2024): 0.40 Billion USD
World Rank (Jul-30-2023): 14589
Market Cap (Jul-30-2023): 0.37 Billion USD
Headquarters Country: USA
- Rank in Search Criteria: 4198
World Rank (Jan-05-2024): 13,988
Market Cap (Jan-05-2024): 0.40 Billion USD
World Rank (Jul-30-2023): 9578
Market Cap (Jul-30-2023): 0.85 Billion USD
World Rank (Jan-2022): 5,045
Market Cap (Jan-2022): 2.84 Billion USDHeadquarters Country: USA Annual Revenue in USD: 271 Million USD
Annual Net Income in USD: -217 Million USD
Annual Results for Period ending: Mar-2022 ending yearEmployee Count: 746
Employee Count as of Date: As on April 2022
Company Profile: 23andMe is the technology to genotype and Biotechnology company. The headquarters is in USA.
Facts About Company: 23andMe company annual revenue was 299 million USD and annual net loss was -311 as on Mar-2023.
- Rank in Search Criteria: 4199
World Rank (Jan-05-2024): 13,993
World Rank (Jul-30-2023): 13993
Market Cap (Jul-30-2023): 0.40 Billion USD
World Rank (Jan-2022): 15,085
Market Cap (Jan-2022): 0.39 Billion USDHeadquarters Country: USA
- Rank in Search Criteria: 4200
World Rank (Jan-05-2024): 13,995
Market Cap (Jan-05-2024): 0.40 Billion USD
World Rank (Jul-30-2023): 12929
Market Cap (Jul-30-2023): 0.49 Billion USD
World Rank (Jan-2022): 5,113
Market Cap (Jan-2022): 2.78 Billion USDHeadquarters Country: USA Annual Revenue in USD: 3,009 Million USD
Annual Net Income in USD: -218 Million USD
Annual Results for Period ending: Dec-2021 ending yearEmployee Count: 6,600
Employee Count as of Date: As on 2021
Company Profile: Rackspace Technology is the Technologies across applications, data and security company enables to grow business, increase efficiency and deliver the future and Multi cloud Solutions company. The headquarters is in USA.
Facts About Company: Rackspace Technology company annual revenue was 3,122 million USD and annual net loss was -804 million USD as on Dec-2022.